Intelligyn

medical devices

About

Intelligyn is a healthcare technology company that specializes in AI-driven clinical decision support systems, particularly for gynecological diagnostics and ovarian cancer detection. Founded in 2022 by Dr. Elisabeth Epstein and her co-founders, the company aims to enhance diagnostic accuracy and accessibility for healthcare professionals, ensuring expert-level care for women everywhere. Intelligyn has developed an AI-powered platform that assists in the ultrasound assessment of ovarian tumors, accurately distinguishing between benign and malignant cases. This platform integrates seamlessly into clinical workflows, providing real-time decision support to doctors and improving diagnostic confidence. The company also offers online medical services focused on medical image assessment, utilizing deep learning techniques to enhance ovarian cancer detection. Intelligyn is actively seeking partnerships to expand the reach of its innovative diagnostic solutions globally, with plans for market release in 2026.

Technologies

Gmail Google Apps Squarespace ECommerce Mobile Friendly Typekit Google Tag Manager YouTube

Keywords

medical equipment manufacturing ai diagnostics cancer risk prediction multicenter validation study healthcare healthcare ai medical image analysis diagnostic workflow ovarian tumor analysis compliance hipaa compliance women's health technology telemedicine data security early cancer detection ai clinical validation ovarian cancer detection dicom compatibility gynecological ultrasound medical software medical imaging ai diagnostic accuracy b2b cloud-based ai ultrasound analysis patient management real-time analysis women's health innovation research and development in the physical engineering

Location

Stockholm, Stockholm County, Sweden

Related Companies

Companies in the same industry